Focused ultrasound gene delivery for the treatment of neurological disorders

Trends Mol Med. 2024 Mar;30(3):263-277. doi: 10.1016/j.molmed.2023.12.006. Epub 2024 Jan 11.

Abstract

The transformative potential of gene therapy has been demonstrated in humans. However, there is an unmet need for non-invasive targeted gene delivery and regulation in the treatment of brain disorders. Transcranial focused ultrasound (FUS) has gained tremendous momentum to address these challenges. FUS non-invasively modulates brain cells and their environment, and is a powerful tool to facilitate gene delivery across the blood-brain barrier (BBB) with millimeter precision and promptly regulate transgene expression. This review highlights technical aspects of FUS-mediated gene therapies for the central nervous system (CNS) and lessons learned from discoveries in other organs. Understanding the possibilities and remaining obstacles of FUS-mediated gene therapy will be necessary to harness remarkable technologies and create life-changing treatments for neurological disorders.

Keywords: blood–brain barrier; focused ultrasound; gene therapy; neurological disorders.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier* / metabolism
  • Brain / metabolism
  • Brain Diseases*
  • Drug Delivery Systems
  • Gene Transfer Techniques
  • Genetic Therapy
  • Humans